Skip to main content
. 2013 Nov;108(7):924–927. doi: 10.1590/0074-0276130084

TABLE. Main features of the plasmid-mediated quinolone resistance-harbouring enterobacteria isolated in this study.

Species Isolate City Hospital qnrB-like allele aac(6’)-Ib / aac(6’)-Ib-cr ESBL genes Phylogenetic group/clone ST MIC (µg/mL)
NAL CIP LEV GAT GEN TOB AMK
Klebisella pneumoniae CM4 CAB H6 qnrB2 -/+ bla CTX-M-15 NC/Kp1 ST11 > 512 > 64 32 16 32 4 4
CL4 CAB H1 qnrB2 -/+ bla CTX-M-15 NC/Kp1 ST11 > 512 > 64 > 64 64 > 64 16 4
I3 SF H5 - -/+ bla CTX-M-15 NC/Kp1 ST11 > 512 > 64 16 16 > 64 32 4
I4 SF H5 - -/+ bla CTX-M-15 NC/Kp1 ST11 > 512 > 64 16 16 64 16 4
CL6 CAB H1 qnrB2 -/+ bla CTX-M-15 NC/Kp2 ST11 > 512 > 64 16 8 1 16 4
CL9 CAB H1 qnrB1 -/+ bla CTX-M-15 NC/Kp3 ST48 64 4 1 2 32 16 2
T8 CH H10 - -/+ bla CTX-M-15 NC/Kp4 ST11 > 512 64 32 16 64 32 4
CV1 CAB H7 qnrB19 +/+ bla CTX-M-15/ bla CTX-M-2 NC/Kp5 ST11 > 512 > 64 64 32 > 64 64 32
L5 CAB H3 qnrB19 -/- bla CTX-M-15 NC/ND ST392 > 512 > 64 4 4 2 16 8
B4 CAB H4 qnrB2 -/- bla CTX-M-15 NC/ND ST11 > 512 64 > 64 64 0.5 1 1
CV2 CAB H7 - -/+ bla CTX-M-2 NC/ND ST15 > 512 64 8 4 < 0.5 4 4
CM1 CAB H6 qnrB19 -/+ bla CTX-M-2 NC/ND ST11 > 512 > 64 64 32 > 64 > 64 > 256
B5 CAB H4 qnrB19 -/- bla CTX-M-2 NC/ND ST11 > 512 64 64 64 > 64 > 64 > 256
CL7 CAB H1 - -/+ bla CTX-M-2 NC/ND ST11 > 512 > 64 16 16 1 8 8
M2 CAB H7 qnrB19 -/- bla CTX-M-2 NC/ND ST11 > 512 > 64 > 64 64 2 16 > 256
CL5 CAB H1 - -/+ bla CTX-M-8 NC/ND ST14 64 8 2 4 1 16 8
Escherichia coli L4 CAB H3 - -/+ bla CTX-M-15 B2/EC1a ST131 > 512 > 64 16 16 1 16 8
T1 CH H10 - -/+ bla CTX-M-15 B2/EC1a ST131 > 512 > 64 64 16 > 64 > 64 16
CM2 CAB H6 - -/+ bla CTX-M-15 B2/EC1b ST131 > 512 > 64 8 8 > 64 32 8
T3 CH H10 - -/+ bla CTX-M-15 B2/EC1b ST131 > 512 64 32 8 1 1 2
SM5 BA H2 - -/+ bla CTX-M-15 B2/EC1c ST131 512 2 1 0.5 2 16 4
M1 CAB H7 - -/+ bla CTX-M-15 A/EC2 ST410 > 512 > 64 32 16 > 64 64 32
SM4 BA H2 - -/+ bla CTX-M-15 A/EC3 ST167 > 512 > 64 64 32 2 16 16
T2 CH H10 qnrB6 -/+ bla CTX-M-2 B1/EC4 ST297 > 512 > 64 > 64 > 64 2 32 4
SM7 BA H2 qnrB2 -/+ bla CTX-M-14 D/EC5 ST68 > 512 > 64 > 64 32 1 1 4
SM8 BA H2 qnrB2 -/- bla CTX-M-14 D/EC5 ST68 > 512 > 64 64 32 < 0.5 0.5 0,5
Klebsiella oxytoca C1 SF H9 - -/+ bla CTX-M-2 NC/ND ND 128 2 4 2 8 16 2
T4 CH H10 qnrB10 -/- bla CTX-M-2 NC/ND ND > 512 64 32 16 > 64 > 64 16
Proteus mirabilis SM6 BA H2 qnrB2 -/- bla CTX-M-2 NC/ND ND > 512 > 64 > 64 64 32 8 4
CX2 BA H8 qnrB10 -/- bla CTX-M-2 NC/ND ND 128 2 4 2 8 16 32
T12 CH H10 qnrB19 -/- bla CTX-M-2 NC/ND ND > 512 32 8 32 64 32 4
Providencia sp. CL2 CAB H1 qnrB2 -/- bla CTX-M-2 NC/ND ND > 512 > 64 > 64 > 64 > 64 64 1
Enterobacter cloacae CX1 BA H8 qnrB10 -/- bla PER-2/ bla SHV-12 NC/ND ND 128 2 4 2 8 16 4

AMK: amikacin; BA: Buenos Aires; CAB: Ciudad Autónoma de Buenos Aires; CH: Chubut; CIP: ciprofloxacin; ESBL: extended-spectrum β-lactamases; GAT: gatifloxacin; GEN: gentamicin; H1: Hospital de Clínicas, Universidad de Buenos Aires; H2: Corporación médica San Martín; H3: Hospital Alemán; H4: Hospital Británico; H5: Hospital Iturraspe; H6: CEMIC; H7: Sanatorio Mater Dei; H8: Hospital Eva Perón; H9: Hospital Cullen; H10: Hospital de Trelew; LEV: levofloxacin; MIC: minimum inhibitory concentration; NAL: nalidixic acid; NC: not correspond; ND: not determined; SF: Santa Fe; TOB: tobramycin.